Cancer: Quo vadis, specificity?

Science

Volumn 319, Issue 5860, 2008, Pages 164-165

  Schreiber, Hans ^a   Rowley, Donald A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HISTONE H4; MELAN A; TUMOR ANTIGEN; VASCULOTROPIN;

ANTIGEN; CANCER; CYTOLOGY; IMMUNE RESPONSE; MUTATION; TUMOR;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; CANCER CELL; CANCER IMMUNOLOGY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SHORT SURVEY; SOMATIC MUTATION; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; AUTOANTIGENS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; HISTONES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MUTATION; PEPTIDE FRAGMENTS; PROSTATIC NEOPLASMS;

EID: 38149131194     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1153713     Document Type: Short Survey

References (12)

1. P. A. Savage et al., Science 319, 215 (2008).
2. M. Miettinen, Adv. Exp. Med. Biol. 587, 99 (2006).
3. B. S. Worley et al., Cancer Res. 61, 6868 (2001).
4. D. Mumberg, M. Wick, H. Schreiber, Semin. Immunol. 8, 289 (1996).
5. L. D. Wood et al., Science 318, 1108 (2007).
6. B. A. Weir et al., Nature 450, 893 ( 2007).
7. G. Klein, H. O. Sögren, E. Klein, K. E. Hellström, Cancer Res. 20, 1561 (1960).
8. Z. Yu et al., J. Clin. Invest. 114, 551 (2004).
9. B. Ludewig et al., J. Exp. Med. 191, 795 (2000).
10. R. A. Morgan et al., Science 314, 126 (2006).
11. P. A. Kiberstis, J. Travis, Science 312, 1157 (2006).
12. M. A. Basombrio, Cancer Res. 30, 2458 (1970).